Gilead Sciences Korea announced it has appointed Jae-Yeon Choi as its new General Manager as of October this year. The position had remained vacant for the past 6 months.

At Gilead Sciences Korea, the new GM Choi will oversee Gilead's business operations in Korea, and promote businesses in the fields of HIV, viral hepatitis, COVID-19, antifungal, and oncology.

After acquiring an MBA from Kellogg School of Management at Northwestern University, Choi accumulated over 20 years of experience in Eli Lilly and MSD, holding leadership roles in various functions including commercial, human resources, drug pricing, and policy, in various regions including the United States, China, and Taiwan.

Eo, Yun-Ho(unkindfish@dailypharm.com)